Clinical Trial Update: A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL [Phase 2]

View source ↗

Summary

A Phase IIb randomized trial evaluating R-ICE chemotherapy with and without SGN-40 for diffuse large B-cell lymphoma/non-Hodgkin lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Rituxan (rituximab)

Snippet

Sponsor: Seagen Inc. | Conditions: Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin | Phase 2 | Status: TERMINATED